• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

Partner Planning Guide

The Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025 (Viral Hepatitis Plan) is a new phase in the fight against viral hepatitis in the United States which aims to eliminate viral hepatitis as a public health threat by 2030. The Viral Hepatitis Plan provides goal-oriented objectives and strategies that can be implemented by a broad mix of stakeholders at all levels and across many sectors, both public and private, to reverse the rates of viral hepatitis, prevent new infections, improve care and treatment and ultimately eliminate viral hepatitis as a public health threat in the United States.

Everyone has a role to play in the battle against viral hepatitis. To support your efforts to build and strengthen viral hepatitis activities, we recommend a resource developed under the previous National Viral Hepatitis Action Plan 2017-2020, the Partner Planning Guide.

The National Viral Hepatitis Action Plan 2017-2020 Partner Planning Guide

The Partner Planning Guide (Guide) is a tool designed for use by individuals, groups, and organizations that are conducting strategic planning efforts for hepatitis B (HBV) and/or hepatitis C (HCV). The Guide can help you, your agency, or organization assess existing activities and plan new ones. It was developed to align with the National Viral Hepatitis Action Plan 2017-2020, but remains useful for strategic planning and implementation of the Viral Hepatitis Plan and contributing toward reaching the national goal to eliminate viral hepatitis as a public health threat.

Tell us what you are doing: If your organization is engaged in activities that are helping reach the goals of the Viral Hepatitis Plan, we want to hear from you. Please contact Jessica Deerin at Jessica.Deerin @hhs.gov to provide information about your activities.

Read more and get involved:

Content created by Office of HIV/AIDS and Infectious Disease Policy
Content last reviewed on March 8, 2018